2018 Year-End Report of State and Local Responses to the Opioid Crisis: Interagency Coordination Plan ACT 88State of Louisiana CLICK HERE TO DOWNLOAD
Tags: Opioid Education, Opioid Prevention
Background Opioid dependence treatment traditionally involves methadone clinics, for which dispensing schedules can be cumbersome. Buprenorphine, a partial agonist of the mu receptor and antagonist of the kappa receptor, is a potential outpatient alternative to methadone. Funded by a grant from the State of Maryland’s Community Health Resources Commission (CHRC), the Buprenorphine Outpatient Outcomes Project
Tags: Louisiana, Opioid Abuse, Patient, prescription
The term “stigma” is used throughout this chapter and the report to represent the complex of attitudes, beliefs, behaviors, and structures that interact at different levels of society (i.e., individuals, groups, organizations, systems) and manifest in prejudicial attitudes about and discriminatory practices against people with mental and substance use disorders. Attention to stigmatizing structures of
Tags: Disorder, Junkie, Substance Abuse
By the end of 2016, the opioid prescribing rate in Louisiana had declined almost 11 percent since 2007. But even with that marked progress, there were still almost enough opioid prescriptions dispensed for every resident in Louisiana to have one, according to the latest data released from the Centers for Disease Control and Prevention. With a
Tags: Louisiana, Opioid Abuse, Patient, prescription